Table 8.
Model | Testing Bal. Acc. | CVC | OR (95% CI) | p |
---|---|---|---|---|
rs2283228 | 0.511 | 5/10 | 1.36 (1.06–1.75) | 0.017 |
rs2237895, rs163177 | 0.509 | 8/10 | 1.63 (1.25–2.13) | <0.001 |
rs2237895, rs2283228, rs163177 | 0.524 | 5/10 | 1.92 (1.49–2.48) | <0.001 |
rs2237895, rs2283228, rs163177, rs8181588 | 0.546 | 9/10 | 2.62 (2.00–3.44) | <0.001 |
rs2237895, rs2283228, rs231356, rs163177, rs8181588 | 0.554 | 10/10 | 3.34 (2.54–4.40) | <0.001 |
rs2237895, rs2283228, rs231356, rs117601636, rs163177, rs8181588 | 0.568 | 10/10 | 4.10 (3.12–5.39) | <0.001 |
rs2237895, rs2283228, rs231356, rs231362, rs117601636, rs163177, rs8181588 | 0.555 | 10/10 | 4.75 (3.59–6.28) | <0.001 |
rs2237895, rs2283228, rs231356, rs231362, rs117601636, rs163177, rs163184, rs8181588 | 0.542 | 10/10 | 5.15 (3.85–6.90) | <0.001 |
Notes: p values were calculated using χ2 tests. Bold indicated that p < 0.05 meant the data was statistically significant.
Abbreviations: MDR, multifactor dimensionality reduction; Bal. Acc., balanced accuracy; CVC, cross–validation consistency; KCNQ1, Potassium Voltage-Gated Channel Subfamily Q Member 1; T2DM, type 2 diabetes mellitus.